Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

As U.S. budget cuts and freezes push healthcare and biopharma research in the States towards uncertainty, could Europe be the destination that science talent flocks towards? That’s what the European ...

With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...

In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...